Piramal to exit drug discovery business3 min read . Updated: 28 Aug 2014, 12:33 AM IST
Group circulates note to 180 employees, mostly scientists, asking them to either retire or move to other Piramal units
Mumbai: Billionaire Ajay Piramal-led Piramal Enterprises Ltd, which sold its India drug formulations business in 2010 to US-based drug maker Abbott Laboratories, has decided to exit from the drug discovery research business after a review meeting this week.
Select your Category